At ONWARD, our team continues to work hard to develop therapies that can make a meaningful difference in the lives of people with spinal cord injury. Recent weeks have delivered the following achievements:
Completion of enrollment in the LIFT Home Study
We announced in early June that we had completed enrollment in the LIFT Home Study. This trial is designed to study the safety and performance of ARCEX Therapy when used in the home. The study enrolled 17 participants at five leading research centers in the US: Craig Hospital in Denver, Colorado, Shepherd Center in Atlanta, Georgia, Spaulding Research Institute in
Boston, Massachusetts, University of Minnesota, and the University of Washington. Participants are followed for four weeks to assess whether continued access to ONWARD’s ARCEX Therapy is safe and can be used to enhance long-term benefit.
The LIFT Home Study is a successor to ONWARD’s Up-LIFT Study, a pivotal trial that completed enrollment of 65 participants in December 2021, with participating research centers in the US, Canada, the UK, and Europe. Up-LIFT is designed to demonstrate ONWARD ARCEX Therapy can improve the strength and function of upper limbs when used in the rehabilitation clinic setting.
Completing these studies is a major step toward the commercialization of ARCEX Therapy for restoration of hand and arm function as expected in 2023. You can learn more here.
Release of “Onward with Scott Chesney” Interview with Erica Coulston
As part of ONWARD’s continuing effort to engage with and learn from the SCI community, Scott Chesney released another in his interview series with leading SCI stakeholders. Erica Coulston, Co-Founder and President of Walk the Line shares her journey as a C6/7 quadriplegic and discusses her interest in potential therapies to restore blood pressure.
As you may recall, ONWARD is working to develop, investigate, and potentially commercialize therapy to address orthostatic hypotension. Watch the interview and subscribe to the series on ONWARD’s YouTube channel.
We expect several important developments later this summer and fall. I will be sure to keep you posted.
Release of “Onward with Scott Chesney” Interview with Erica Coulston
As part of ONWARD’s continuing effort to engage with and learn from the SCI community, Scott Chesney released another in his interview series with leading SCI stakeholders. Erica Coulston, Co-Founder and President of Walk the Line shares her journey as a C6/7 quadriplegic and discusses her interest in potential therapies to restore blood pressure.
As you may recall, ONWARD is working to develop, investigate, and potentially commercialize therapy to address orthostatic hypotension. Watch the interview and subscribe to the series on ONWARD’s YouTube channel.
We expect several important developments later this summer and fall. I will be sure to keep you posted.
Best wishes,
Dave
Dave Marver
CEO
Best wishes,
Dave
Dave Marver
CEO